Cargando…
Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2
Autores principales: | Skayem, Charbel, Ayoub, Nakhle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833103/ https://www.ncbi.nlm.nih.gov/pubmed/32631576 http://dx.doi.org/10.1016/j.amjms.2020.05.030 |
Ejemplares similares
-
Myopathy associated with severe SARS-CoV-2 infection
por: Abenza Abildúa, M.J., et al.
Publicado: (2020) -
Carvedilol for the treatment of red scrotum syndrome
por: Merhi, Ribal, et al.
Publicado: (2017) -
Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection()()
por: O'Moráin, N, et al.
Publicado: (2022) -
Hemorrhagic stroke in hispanics with severe SARS-CoV2 infection
por: Castillo, P.R., et al.
Publicado: (2020) -
Giardiasis reactivation during severe SARS-CoV-2 infection
por: Lupia, Tommaso, et al.
Publicado: (2021)